News Archive
In 2020, Cures Within Reach funded Dr. Aileen Chang at George Washington University to support a Phase I trial evaluating the safety and efficacy of an approved flu drug, zanamivir, for patients with severe dengue infections in Colombia.
Dengue viruses (DenV) are among the leading causes of pediatric morbidity and mortality globally, with 96 million symptomatic cases annually worldwide and no targeted treatments.
Aileen Y. Chang, MD, MSPH, FACP, associate professor of medicine at the George Washington University School of Medicine and Health Sciences received the 2023 Innovative Research Award from the Rheumatology Research Foundation for her research project titled, Determination of the Human Mechanisms…
It’s hard to recall a more important time for groundbreaking scientific research when it comes to the health and safety of the United States than in the past six months; by October the country had recorded more than 7 million cases of the novel coronavirus, and the global toll passed 1 million…
George Washington University (GW) researcher Aileen Chang, MD, MSPH, is a finalist for CureAccelerator Live! for the Developing World. The event is a philanthropic pitch competition that gives attendees the chance to select and award $50,000 of funding for the next breakthrough clinical…